Thymoma is known to contain CD4+CD8+ T cells, indicating that neoplastic epithelial cells of
thymoma have a function as thymic cortical epithelium. However, it has been shown that there is an impairment of CD4+ T cell development in
thymoma and that IFN-gamma-induced
HLA-DR expression on cultured thymic epithelial cells (TEC) derived from
thymoma is decreased when compared with the normal thymus. MHC
class II transactivator (CIITA) is known to play a critical role in IFN-gamma-induced MHC II expression. In this study, we attempted to elucidate whether CIITA is responsible for the impaired up-regulation of
MHC II molecules in response to IFN-gamma in
thymoma TEC. A quantitative reverse transriptase-polymerase chain reaction examination revealed that the induced level of CIITA was significantly lower in
thymoma TEC than in normal TEC. The induced levels of
invariant chain (Ii) and
HLA-DR in
thymoma TEC were correlated with CIITA expression. The proportion of CD3+ cells in the CD4+CD8- subset in
thymoma was also correlated with CIITA expression. A gel mobility shift assay however, revealed translocation of STAT1 to the nucleus in
thymoma as well as normal TEC.
Intercellular adhesion molecule-1 was up-regulated in the
thymoma TEC to a level similar to normal TEC in response to IFN-gamma. These results indicate that impaired up-regulation of
HLA-DR in response to IFN-gamma results from insufficient induction of CIITA, but not from the signal from IFN-gamma receptor to the nucleus. The abnormal regulation of
HLA-DR expression caused by impaired induction of CIITA may affect CD4+ T cell development in
thymoma.